Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Expert Opinion on Investigational Drugs
|
August 2, 2002
HIV-1 regulatory proteins: targets for novel drug development
Roger G Ptak
Journal of Medicinal Chemistry
|
October 29, 2004
Synthesis, antiviral activity, and mode of action of some 3-substituted 2,5,6-trichloroindole 2'- and 5'-deoxyribonucleosides
John D Williams, Roger G Ptak, John C Drach, et al.
Bioorganic & Medicinal Chemistry
|
June 13, 2006
Nucleosides with self-complementary hydrogen-bonding motifs: synthesis and base-pairing studies of two nucleosides containing the imidazo[4,5-d]pyridazine ring system
Ravi K Ujjinamatada, Robin L Paulman, Roger G Ptak, et al.
Journal of Medicinal Chemistry
|
September 21, 2011
Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41
Guangyan Zhou, Dong Wu, Beth Snyder, et al.
Journal of Chemical Information and Modeling
|
October 11, 2014
Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication
Sandhya Kortagere, Jimmy P Xu, Marie K Mankowski, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 21, 2003
Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs
Gloria Komazin, Roger G Ptak, Brian T Emmer, et al.
Vaccine
|
December 17, 2008
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen
Mei-Yun Zhang, Yanping Wang, Marie K Mankowski, et al.
Advances in Virology
|
October 28, 2020
HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
Raj Kalkeri, Junzhong Peng, Chunsheng Huang, et al.
Journal of Virology
|
October 15, 2003
Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27
Gloria Komazin, Roger G Ptak, Brian T Emmer, et al.
The Journal of Biological Chemistry
|
June 11, 2011
Highly potent chimeric inhibitors targeting two steps of HIV cell entry
Bo Zhao, Marie K Mankowski, Beth A Snyder, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Expert Opinion on Investigational Drugs
|
August 2, 2002
HIV-1 regulatory proteins: targets for novel drug development
Roger G Ptak
Journal of Medicinal Chemistry
|
October 29, 2004
Synthesis, antiviral activity, and mode of action of some 3-substituted 2,5,6-trichloroindole 2'- and 5'-deoxyribonucleosides
John D Williams, Roger G Ptak, John C Drach, et al.
Bioorganic & Medicinal Chemistry
|
June 13, 2006
Nucleosides with self-complementary hydrogen-bonding motifs: synthesis and base-pairing studies of two nucleosides containing the imidazo[4,5-d]pyridazine ring system
Ravi K Ujjinamatada, Robin L Paulman, Roger G Ptak, et al.
Journal of Medicinal Chemistry
|
September 21, 2011
Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41
Guangyan Zhou, Dong Wu, Beth Snyder, et al.
Journal of Chemical Information and Modeling
|
October 11, 2014
Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication
Sandhya Kortagere, Jimmy P Xu, Marie K Mankowski, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 21, 2003
Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs
Gloria Komazin, Roger G Ptak, Brian T Emmer, et al.
Vaccine
|
December 17, 2008
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen
Mei-Yun Zhang, Yanping Wang, Marie K Mankowski, et al.
Advances in Virology
|
October 28, 2020
HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
Raj Kalkeri, Junzhong Peng, Chunsheng Huang, et al.
Journal of Virology
|
October 15, 2003
Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27
Gloria Komazin, Roger G Ptak, Brian T Emmer, et al.
The Journal of Biological Chemistry
|
June 11, 2011
Highly potent chimeric inhibitors targeting two steps of HIV cell entry
Bo Zhao, Marie K Mankowski, Beth A Snyder, et al.
Page
of 6